Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value. advertisement Apellis shares rose 32% last week, with most of the gains ...Jul 20, 2023 ... About Apellis Pharmaceuticals Inc (APLS). Before we jump into Apellis Pharmaceuticals Inc's stock price, history, target price and what caused ...Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application. WALTHAM, Mass., Jan. 26, …Oct 31, 2023 · Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength Stocks With Rising Relative Price Strength: Apellis Pharmaceuticals Meta Stock, Nvidia, Toyota, Alphabet And 12 Others Enter ... Buying $100 In APLS: If an investor had bought $100 of APLS stock 5 years ago, it would be worth $451.80 today based on a price of $67.59 for APLS at the time of …APLS Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. APELLIS PHARMACEUTICALS, INC. (APLS) Compare. APELLIS PHARMACEUTICALS, ...Feb 23, 202406:27 PST. Investors are always looking for stocks that are poised to beat at earnings season and Apellis Pharmaceuticals, Inc. APLS may be one …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Jul 31, 2023 ... ... costs, and an increase in director stock option compensation. Net Loss. Apellis reported a net loss of $122.0 million for the second quarter ...View live Apellis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, APLS financials and market news.Apellis Pharmaceuticals Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 18 analysts with 12-month price forecasts for APLS stock have an average target of 77.17, with a low estimate of 42 and a high estimate of 141. The average target predicts an increase of 12.20% from the current stock price of 68.78.Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.15 brokers have issued 12 month target prices for Apellis Pharmaceuticals' shares. Their APLS share price targets range from $54.00 to $106.00. On average, they …NasdaqGS - NasdaqGS Real Time Price. Currency in USD. 68.78 +1.20 (+1.78%) At close: 04:00PM EST. 68.80 +0.02 (+0.03%) After hours: 08:00PM EST. Loading interactive …APLS | Complete Apellis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...15 brokers have issued 12 month target prices for Apellis Pharmaceuticals' shares. Their APLS share price targets range from $54.00 to $106.00. On average, they …Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value. advertisement Apellis shares rose 32% last week, with most of the gains ...Evolution of the average Target Price on Apellis Pharmaceuticals, Inc. Price target over the last 5 years. History of analyst recommendation changes. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ +229% on MICROSOFT CORPORATION since our purchase on January 11, 2019.Apellis Pharmaceuticals ( NASDAQ: APLS) lost ~2% in the pre-market Friday after announcing that updated labeling information for its FDA-approved eye disease therapy Syfovre reflects risks related ...Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic …Oct 6, 2023 ... J. P. Morgan analyst boosted the company from neutral to overweight and raised their price target to $81 a share. This comes as the company ...67.59 +0.70 1.05% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert Draw Ideas …Apellis Pharmaceuticals shows improving price ... IBD's proprietary RS Rating measures market leadership by showing how a stock's price action over the last 52 weeks measures up against that ...Apellis Pharmaceuticals, Inc. price-consensus-chart | Apellis Pharmaceuticals, Inc. Quote. Zacks Rank and Other Stocks to Consider. Apellis currently carries a Zacks Rank #2 (Buy).Feb 16, 2024 · What was Apellis Pharmaceuticals Inc’s price range in the past 12 months? Apellis Pharmaceuticals Inc lowest stock price was $19.83 and its highest was $94.75 in the past 12 months. What is Apellis Pharmaceuticals Inc’s market cap? Apellis Pharmaceuticals Inc Stock Price History. Apellis Pharmaceuticals Inc’s price is currently down 2.79% so far this month. During the month of November, Apellis Pharmaceuticals Inc’s stock price has reached a high of $51.74 and a low of $41.19. Over the last year, Apellis Pharmaceuticals Inc has hit prices as high as $94.75 …Jan 08, 2024 Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues. Dec 14, 2023 8:30 AM EST. Click here for webcast. Investor Contact. Meredith Kaya. (617) 599-8178. [email protected]. Lissa Pavluk. (617) 977-6764.In depth view into APLS (Apellis Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Jan 30, 2024 · Apellis Pharmaceuticals, Inc. (1JK.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Apellis Pharmaceuticals, Inc. | BOERSE ... Jan 31, 2018 · Wall Street Analysts Predict a 51.91% Upside in Apellis Pharmaceuticals, Inc. (APLS): Here's What You Should Know. (Zacks) Oct-25-23 07:00AM. Apellis Pharmaceuticals to Host Conference Call on November 1, 2023, to Discuss Third Quarter 2023 Financial Results. With a net margin of -127.03%, the company may encounter challenges in effective cost control. Return on Equity (ROE): Apellis Pharmaceuticals's ROE is ... quarterly ratings for individual stocks.Feb 14, 2024 · The latest price target for . Apellis Pharmaceuticals (NASDAQ: APLS) was reported by Baird on Tuesday, February 6, 2024.The analyst firm set a price target for 81.00 expecting APLS to rise to ... The Apellis Pharmaceuticals stock prediction for 2025 is currently $ 88.93, assuming that Apellis Pharmaceuticals shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 29.88% increase in the APLS stock price. Apellis Pharmaceuticals Stock Prediction 2030 Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price. 4 days ago · The Apellis Pharmaceuticals Inc. stock price gained 0.646% on the last trading day (Friday, 9th Feb 2024), rising from $68.12 to $68.56. During the last trading day the stock fluctuated 1.89% from a day low at $68.11 to a day high of $69.40. The price has risen in 6 of the last 10 days and is up by 7.06% over the past 2 weeks. Apellis Pharmaceuticals Inc (APLS) stock has gained 4.16% while the S&P 500 is lower by -0.31% as of 11:15 AM on Tuesday, Jan 9. APLS has risen $2.85 from the previous closing price of $68.35 on volume of 1,003,015 shares. Over the past year the S&P 500 has risen 22.01% while APLS has risen 49.31%.On January 17, 2024, Jeffrey Eisele, Chief Development Officer of Apellis Pharmaceuticals Inc (NASDAQ:APLS), sold 5,207 shares of the company's stock, according to a recent SEC Filing. Get the ... Since its approval, rare but serious side effects have marred an otherwise steady launch in the U.S., depressing Apellis’ stock price and, in October, triggering a major restructuring. Though Apellis has blamed faulty needles, not the treatment, for the safety problems, two weeks ago the FDA added a warning to Syfovre’s prescribing …Apellis Pharmaceuticals Inc. (APLS) is a biotechnology company that develops and commercializes therapies for rare diseases. The stock price, …Nov 30, 2023 ... Apellis Pharmaceuticals Inc (APLS) stock is trading at $52.70 as of 10:56 AM on Thursday, Nov 30, an increase of $2.40, or 4.76% from the ...Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Apellis Pharmaceuticals, Inc. Price and Consensus. Apellis Pharmaceuticals, Inc. Price and Consensus. ... As China grapples with the fallout from a $7 trillion stock decline, officials are gearing ...Apellis Pharmaceuticals ( NASDAQ: APLS) lost ~2% in the pre-market Friday after announcing that updated labeling information for its FDA-approved eye disease therapy Syfovre reflects risks related ...With an $85 price objective, which significantly exceeds the current trading price, the report reflects a bullish stance on Apellis Pharmaceuticals’s financial prospects and market positioning ...Nov 30, 2023 · For instance, the price of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stock is up an impressive 177% over the last five years. It's also good to see the share price up 19% over the last quarter. The 55 analysts offering price forecasts for Norwegian Cruise Line have a median target of 18.15, with a high estimate of 33.00 and a low estimate of 11.50. The median estimate represents a 89.66 ...APLS. -1.09%. Apellis Pharma (APLS) stock experienced a sharp pre-market decline following news that it anticipates a negative opinion from a European regulator on Pegcetacoplan at its upcoming ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...Feb 19, 2024 · Summary of all time highs, changes and price drops for Apellis Pharmaceuticals; Historical stock prices; Current Share Price: US$68.78: 52 Week High: US$94.75 Aug 3, 2023 ... In the nearly three weeks since then, Apellis shares have nosedived 73%. That decline began with a 38% drop-off from $84.50 to $52.46 on the day ...Nov 13, 2017 ... ... shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. The shares ...4 days ago · 15 brokers have issued 12 month target prices for Apellis Pharmaceuticals' shares. Their APLS share price targets range from $54.00 to $106.00. On average, they expect the company's stock price to reach $75.93 in the next year. This suggests a possible upside of 10.4% from the stock's current price. What's Happening With APLS Stock Today? Apellis Pharmaceuticals Inc (APLS) stock has gained 4.16% while the S&P 500 is lower by -0.31% as of 11:15 AM on Tuesday, Jan 9. APLS has risen $2.85 from the previous closing price of $68.35 on volume of 1,003,015 shares. Over the past year the S&P 500 has risen 22.01% while APLS has …MT. Apellis Pharmaceuticals Insider Sold Shares Worth $469,905, According to a Recent SEC Filing. Jan. 24. MT. Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating. Jan. 24. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing. Jan. 24. Jul 19, 2023 ... With A 55% Price Drop For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) You'll Still Get What You Pay For · How Is Apellis Pharmaceuticals' Revenue&nb...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. ... Apellis Pharmaceuticals Inc stock performance at a glance. Check Apellis Pharmaceuticals Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.67.59 +0.70 1.05% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert Draw Ideas …Jul 20, 2023 ... About Apellis Pharmaceuticals Inc (APLS). Before we jump into Apellis Pharmaceuticals Inc's stock price, history, target price and what caused ...Oct 6, 2023 ... J. P. Morgan analyst boosted the company from neutral to overweight and raised their price target to $81 a share. This comes as the company ...Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) WALTHAM, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to 4 new employees with a grant date of February 1, 2024, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but ... Today's Low 52 Week High 52 Week Low Data Provided by Refinitiv. Minimum 15 minutes delayed. Historical Price Lookup Lookup Month February Lookup …Apellis Pharmaceuticals, Inc. Price and Consensus. Apellis Pharmaceuticals, Inc. Price and Consensus. ... As China grapples with the fallout from a $7 trillion stock decline, officials are gearing ...The company has a 12-month price target of $74.75. 16 analysts have recently shared their evaluations of Apellis pharmaceuticals. The average price target has risen 5.28% in the last three months. Apell is Pharmaceuticals has a high estimate of $106.00 and a low estimate of £42.00. Benzinga · 2d ago.Find the latest Apellis Pharmaceuticals Inc (APLS) stock forecast, 12-month price target, predictions and analyst recommendations.Apellis Pharmaceuticals shows improving price ... IBD's proprietary RS Rating measures market leadership by showing how a stock's price action over the last 52 weeks measures up against that ...November 2, 2023 · 6 min read. Apellis Pharmaceuticals, Inc. APLS reported third-quarter 2023 loss of $1.17 per share, which was wider than the Zacks Consensus Estimate of a loss of 84 cents. The ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...This price target is based on 15 analysts offering 12 month price targets for Apellis Pharmaceuticals in the last 3 months. The average price target is $75.93, with a high forecast of $106.00 and a low forecast of $54.00. The average price target represents a 12.34% upside from the last price of $67.59.Apellis (APLS) stock falls on the CHMP's negative recommendation to the EMA regarding the approval of intravitreal pegcetacoplan in the EU for the treatment of geographic atrophy secondary to age ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...The news caused Apellis’ stock price to sink nearly 32% to $52.62 by Monday afternoon. The drug's overall real-world safety profile has been "consistent" with its clinical trials, an Apellis ...Apellis Pharmaceuticals (APLS, $67.6) entered Uptrend as Momentum indicator ascends above 0 level on Feb 22, 2024 Tickeron - Stocks • 2 days ago This indicator may be signaling APLS's price has momentum to move higher, since its current price moved above its price 14 days ago.Track Apellis Pharmaceuticals Inc (APLS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors APLS, Apellis Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines ... Stocks With Rising Relative Price Strength: Apellis Pharmaceuticals Investor's Business Daily 01/17/2024 03:00 AM ET. Meta Stock, Nvidia, Toyota ...Jul 20, 2023 ... About Apellis Pharmaceuticals Inc (APLS). Before we jump into Apellis Pharmaceuticals Inc's stock price, history, target price and what caused ...APLS, Apellis Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Oct 6, 2023 ... J. P. Morgan analyst boosted the company from neutral to overweight and raised their price target to $81 a share. This comes as the company ...MSFT. Microsoft Corporation Common Stock. $371.19 +0.57 +0.15%. Apellis Pharmaceuticals, Inc. Common Stock (APLS) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ...Apellis Pharmaceuticals, Inc. (APLS) Stock Price | Stock Quote Nasdaq - MarketScreener APELLIS PHARMACEUTICALS, INC. PDF Report Apellis Pharmaceuticals, Inc. Stock …Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.APLS | Complete Apellis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06. The company has a debt-to-equity ratio of 0.40, a quick ratio of 3.76 and a current ratio of 4.29. Apellis Pharmaceuticals, Inc. has a twelve month low of $19.83 and a twelve month high of $94.75.Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.The firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06. The company has a debt-to-equity ratio of 0.40, a quick ratio of 3.76 and a current ratio of 4.29. Apellis Pharmaceuticals, Inc. has a twelve month low of $19.83 and a twelve month high of $94.75.
Apellis Pharmaceuticals, Inc. Common Stock (APLS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. . Appending strings
Feb 16, 2024 · Despite its mid-2023 stock price collapse, Apellis stock has typically delivered strong value for investors. Its stock price is +385% over a 5-year period, and +122% over a 6-month period as it ... Aug 14, 2023 ... What's behind the recent surge in Apellis' stock price? Growing confidence in the safety of its eye treatment ... Shares of Apellis ...Oct 6, 2023 ... an upgrade to "Buy" from Jefferies analysts. Apellis Pharmaceuticals (APLS) stock ... price target. Lastly, Oppenheimer downgrades AutoZone (AZO) ...Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Shares of Apellis Pharmaceuticals Inc (NASDAQ: APLS) declined following a Deutsch. Español. India ... Price Action: APLS stock is down 5.68% at $44.17 on the last check Monday.Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $469,905, According to a Recent SEC Filing. Jan. 24. MT. Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating. Jan. 24. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing. Jan. 24. Apellis Pharmaceuticals, Inc. Common Stock (APLS) Nasdaq Listed; ... Analyze your stocks, ... You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.Mar 11, 2019 ... ... shares at the public offering price, less underwriting discounts and commissions. All of the shares in the offering were sold by Apellis.Related news Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength. 1/29/2024 Apellis Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative ...This price target is based on 15 analysts offering 12 month price targets for Apellis Pharmaceuticals in the last 3 months. The average price target is $75.93, with a high forecast of $106.00 and a low forecast of $54.00. The average price target represents a 12.34% upside from the last price of $67.59.Compact, single-use, on-body injector designed to enhance the patient experience of administering EMPAVELI ® (pegcetacoplan); WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved the …Jan 26, 2024 · Feb 20, 2024 Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results; Feb 06, 2024 Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) The drug continues to be one of the growth drivers for Apellis, with reported revenues of almost $66.6 million in the first nine months of 2023. Shares of Apellis have rallied 19.1% year to date ...4 days ago · The average twelve-month price prediction for Apellis Pharmaceuticals is $75.93 with a high price target of $106.00 and a low price target of $54.00. Learn more on APLS's analyst rating history. Do Wall Street analysts like Apellis Pharmaceuticals more than its competitors? Analysts like Apellis Pharmaceuticals more than other Medical companies. Discover historical prices for APLS stock on Yahoo Finance. View daily, weekly or monthly format back to when Apellis Pharmaceuticals, Inc. stock was issued. 5 days ago · View Apellis Pharmaceuticals, Inc APLS investment & stock information. Get the latest Apellis Pharmaceuticals, Inc APLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The Apellis eye drug rebound accelerates. This time, ... Astellas, also recently approved, may have stumbled, which could further boost Apellis’ business outlook — and its stock price..